Smith NJ et al. |
Reduced cerebral vascularization in experimental neuronopathic Gaucher disease. |
2018 |
J. Pathol. |
pmid:28981147
|
Lukas J et al. |
Glucosylsphingosine Causes Hematological and Visceral Changes in Mice-Evidence for a Pathophysiological Role in Gaucher Disease. |
2017 |
Int J Mol Sci |
pmid:29053611
|
Kang L et al. |
Successful newborn screening for Gaucher disease using fluorometric assay in China. |
2017 |
J. Hum. Genet. |
pmid:28356566
|
Taguchi YV et al. |
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease. |
2017 |
J. Neurosci. |
pmid:28847804
|
Franco M et al. |
Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease. |
2017 |
Am. J. Hematol. |
pmid:28621801
|
Murugesan V et al. |
Glucosylsphingosine is a key biomarker of Gaucher disease. |
2016 |
Am. J. Hematol. |
pmid:27441734
|
Dai M et al. |
Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease. |
2016 |
PLoS ONE |
pmid:27598339
|
Gramlich PA et al. |
A peptide-linked recombinant glucocerebrosidase for targeted neuronal delivery: Design, production, and assessment. |
2016 |
J. Biotechnol. |
pmid:26795355
|
Dasgupta N et al. |
Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model. |
2015 |
Hum. Mol. Genet. |
pmid:26420838
|
Sun Y et al. |
Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology. |
2015 |
PLoS ONE |
pmid:25822147
|
Burrow TA et al. |
CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings. |
2015 |
Mol. Genet. Metab. |
pmid:25219293
|
Fuller M et al. |
Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool. |
2015 |
Clin. Chim. Acta |
pmid:26232157
|
Mirzaian M et al. |
Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard. |
2015 |
Blood Cells Mol. Dis. |
pmid:25842368
|
Aflaki E et al. |
Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs. |
2014 |
Sci Transl Med |
pmid:24920659
|
Gaspar P et al. |
Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis. |
2014 |
J. Lipid Res. |
pmid:24212238
|
Angka L et al. |
Glucopsychosine increases cytosolic calcium to induce calpain-mediated apoptosis of acute myeloid leukemia cells. |
2014 |
Cancer Lett. |
pmid:24631520
|
Welford RW et al. |
Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. |
2014 |
PLoS ONE |
pmid:25479233
|
Sardi SP et al. |
Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23297226
|
Sun Y et al. |
Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher disease. |
2013 |
PLoS ONE |
pmid:23520473
|
Pavlova EV et al. |
B cell lymphoma and myeloma in murine Gaucher's disease. |
2013 |
J. Pathol. |
pmid:23775597
|